These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 19801969)
1. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Chen YH; Gao J; Fan G; Peterson LC Mod Pathol; 2010 Jan; 23(1):105-12. PubMed ID: 19801969 [TBL] [Abstract][Full Text] [Related]
2. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535 [TBL] [Abstract][Full Text] [Related]
3. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697 [TBL] [Abstract][Full Text] [Related]
4. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Ribera-Cortada I; Martinez D; Amador V; Royo C; Navarro A; Beà S; Gine E; de Leval L; Serrano S; Wotherspoon A; Colomer D; Martinez A; Campo E Mod Pathol; 2015 Nov; 28(11):1435-47. PubMed ID: 26360498 [TBL] [Abstract][Full Text] [Related]
5. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma. Beà S; Amador V Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437 [TBL] [Abstract][Full Text] [Related]
6. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma. Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745 [TBL] [Abstract][Full Text] [Related]
7. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Dictor M; Ek S; Sundberg M; Warenholt J; György C; Sernbo S; Gustavsson E; Abu-Alsoud W; Wadström T; Borrebaeck C Haematologica; 2009 Nov; 94(11):1563-8. PubMed ID: 19880779 [TBL] [Abstract][Full Text] [Related]
8. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Mozos A; Royo C; Hartmann E; De Jong D; Baró C; Valera A; Fu K; Weisenburger DD; Delabie J; Chuang SS; Jaffe ES; Ruiz-Marcellan C; Dave S; Rimsza L; Braziel R; Gascoyne RD; Solé F; López-Guillermo A; Colomer D; Staudt LM; Rosenwald A; Ott G; Jares P; Campo E Haematologica; 2009 Nov; 94(11):1555-62. PubMed ID: 19880778 [TBL] [Abstract][Full Text] [Related]
9. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940 [TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Zukerberg LR; Yang WI; Arnold A; Harris NL Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927 [TBL] [Abstract][Full Text] [Related]
12. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma? Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893 [TBL] [Abstract][Full Text] [Related]
13. Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma. Chuang WY; Chang H; Shih LY; Lin TC; Yeh CJ; Ueng SH; Kuo MC; Kao HW; Liu H; Chang ST; Lee CL; Huang KP; Wang TH; Wan YL; Yu JS; Hsueh C; Chuang SS Virchows Arch; 2024 Aug; 485(2):323-334. PubMed ID: 38733379 [TBL] [Abstract][Full Text] [Related]
15. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas. Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas. Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898 [TBL] [Abstract][Full Text] [Related]
17. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553 [TBL] [Abstract][Full Text] [Related]
18. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493 [TBL] [Abstract][Full Text] [Related]
19. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma. Zapata M; Budnick SD; Bordoni R; Li S Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333 [TBL] [Abstract][Full Text] [Related]
20. Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders. Nakashima MO; Durkin L; Bodo J; Lin J; Quintanilla-Martinez L; Fu K; Hsi ED Appl Immunohistochem Mol Morphol; 2014; 22(10):720-7. PubMed ID: 25229384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]